Publications by authors named "Jennifer Grunfeld"

Claim this Profile
B
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
Stephen Macfarlane, Timo Grimmer, Ken Teo, Terence J O'Brien, Michael Woodward, Jennifer Grunfeld

J Prev Alzheimers Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Treatment Preferences of Australian Patients Living with Treatment-Resistant Depression.
Simon Fifer, Andrea Puig, Vanessa Sequeira, Mustafa Acar, Chee H Ng, Jennifer Grunfeld

Patient Prefer Adherence· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study.
Mark E Schmidt, Michael R Liebowitz, Murray B Stein, Jennifer Grunfeld, Ilse Van Hove

Neuropsychopharmacology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2).
Ewa Wajs, Leah Aluisio, Richard Holder, Ella J Daly, Rosanne Lane, Jennifer Grunfeld

J Clin Psychiatry· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis